Product NDC: | 0264-9872 |
Proprietary Name: | Heparin Sodium in Sodium Chloride |
Non Proprietary Name: | Heparin Sodium in Sodium Chloride |
Active Ingredient(s): | 200 [USP'U]/100mL & nbsp; Heparin Sodium in Sodium Chloride |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0264-9872 |
Labeler Name: | B. Braun Medical Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019953 |
Marketing Category: | NDA |
Start Marketing Date: | 19920720 |
Package NDC: | 0264-9872-10 |
Package Description: | 24 CONTAINER in 1 CASE (0264-9872-10) > 500 mL in 1 CONTAINER |
NDC Code | 0264-9872-10 |
Proprietary Name | Heparin Sodium in Sodium Chloride |
Package Description | 24 CONTAINER in 1 CASE (0264-9872-10) > 500 mL in 1 CONTAINER |
Product NDC | 0264-9872 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Heparin Sodium in Sodium Chloride |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19920720 |
Marketing Category Name | NDA |
Labeler Name | B. Braun Medical Inc. |
Substance Name | HEPARIN SODIUM |
Strength Number | 200 |
Strength Unit | [USP'U]/100mL |
Pharmaceutical Classes | Anti-coagulant [EPC],Heparin [Chemical/Ingredient],Unfractionated Heparin [EPC] |